- Home
- GITS vs VTAK Comparison
GITS vs VTAK Comparison
Compare GITS & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GITS
- VTAK
- Stock Information
- Founded
- GITS 2018
- VTAK 2002
- Country
- GITS South Korea
- VTAK United States
- Employees
- GITS N/A
- VTAK N/A
- Industry
- GITS
- VTAK Medical/Dental Instruments
- Sector
- GITS
- VTAK Health Care
- Exchange
- GITS Nasdaq
- VTAK Nasdaq
- Market Cap
- GITS 4.1M
- VTAK 3.9M
- IPO Year
- GITS N/A
- VTAK 2018
- Fundamental
- Price
- GITS $2.18
- VTAK $2.48
- Analyst Decision
- GITS
- VTAK
- Analyst Count
- GITS 0
- VTAK 0
- Target Price
- GITS N/A
- VTAK N/A
- AVG Volume (30 Days)
- GITS 27.5K
- VTAK 3.1M
- Earning Date
- GITS 08-15-2025
- VTAK 08-11-2025
- Dividend Yield
- GITS N/A
- VTAK N/A
- EPS Growth
- GITS N/A
- VTAK N/A
- EPS
- GITS N/A
- VTAK N/A
- Revenue
- GITS $29.00
- VTAK $600,000.00
- Revenue This Year
- GITS N/A
- VTAK $822.86
- Revenue Next Year
- GITS N/A
- VTAK $168.42
- P/E Ratio
- GITS N/A
- VTAK N/A
- Revenue Growth
- GITS N/A
- VTAK 37.62
- 52 Week Low
- GITS $0.87
- VTAK $2.39
- 52 Week High
- GITS $9.78
- VTAK $42.75
- Technical
- Relative Strength Index (RSI)
- GITS 46.10
- VTAK 38.93
- Support Level
- GITS $2.12
- VTAK $2.39
- Resistance Level
- GITS $2.34
- VTAK $3.13
- Average True Range (ATR)
- GITS 0.16
- VTAK 0.27
- MACD
- GITS -0.00
- VTAK -0.02
- Stochastic Oscillator
- GITS 35.00
- VTAK 4.64
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About VTAK Catheter Precision Inc.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.